Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. immune inflammatory
Show results for
Products
Services

Companies

News
Articles
Downloads

Refine by
Date

  • Older

Immune Inflammatory Articles & Analysis: Older

8 news found

Treating Acute Inflammatory Lung Disease: The Promise of Trimannose-Coupled Antimir-21

Treating Acute Inflammatory Lung Disease: The Promise of Trimannose-Coupled Antimir-21

Recent advances in the fight against severe acute inflammatory lung diseases, including COVID-19, have revealed a promising new approach to treating pulmonary hyperinflammation and long-term lung damage such as fibrosis. A groundbreaking study has developed a first-in-class, carbohydrate-coupled inhibitor of microRNA-21 (RCS-21), which shows significant potential as a therapeutic agent. This ...

BySCIREQ - an emka TECHNOLOGIES Company


Alfa Chemistry Newly Introduces Three APIs to Meet Market Demands: Tofacitinib Citrate, Tamoxifen Citrate, and Epalrestat

Alfa Chemistry Newly Introduces Three APIs to Meet Market Demands: Tofacitinib Citrate, Tamoxifen Citrate, and Epalrestat

Tofacitinib Citrate Tofacitinib Citrate is a medication used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. It works by suppressing the immune system and reducing inflammation in the body. Tofacitinib Citrate is a selective inhibitor of Janus kinase (JAK) enzymes, which play a key role in immune response and ...

ByAlfa Chemistry


Creative Proteomics Cytokine Boosts Your Research and Discovery with Mouse Cytokine Assay

Creative Proteomics Cytokine Boosts Your Research and Discovery with Mouse Cytokine Assay

Creative Proteomics Cytokine recently launched the Mouse Cytokine Assay with high sensitivity to support research in immune responses, inflammatory diseases, allergies, sepsis, and cancer. Cytokines play an important role in physiological and pathological processes such as immune cell differentiation and subset development, ...

ByCreative Proteomics


Cipla enters partnership to provide affordable oncology biosimilars to South Africa

Cipla enters partnership to provide affordable oncology biosimilars to South Africa

Cipla also recently launched a biosimilar for the treatment of immune-mediated inflammatory disease. According to the Cancer Alliance report CA03/2021, South Africa faces a crisis in terms of affordable access to medicines, particularly in the treatment of cancer. ...

BymAbxience


New, late-breaking data at EADV highlights emerging clinical profile of amlitelimab (formerly KY1005) in adults with inadequately controlled moderate-to-severe atopic dermatitis

New, late-breaking data at EADV highlights emerging clinical profile of amlitelimab (formerly KY1005) in adults with inadequately controlled moderate-to-severe atopic dermatitis

“The amlitelimab data presented at EADV support our belief that OX40-Ligand has the potential to provide a novel approach to treating a range of immune-mediated diseases," said Naimish Patel, M.D. Head of Global Development in Immunology and Inflammation at Sanofi. ...

ByKiadis Pharma NV


Nanobodies and CAR-T

Nanobodies and CAR-T

Researchers from Boston Children’s Hospital and MIT took mini-antibodies from alpacas Bryson and Sanchez. Then they shrunk the mini-antibodies into even smaller nanobodies and engineered these nanobodies onto CAR-T cells. During this process, they discovered a new form of cell therapy. The goal is to enhance CAR-T cells’ targeting abilities by targeting immunosuppressive proteins in ...

ByIMAPAC


Servier and Poietis announce scientific partnership in 4D bioprinting of liver tissues

Servier and Poietis announce scientific partnership in 4D bioprinting of liver tissues

” “This new technology’s ability to include different cell types within a single extracellular matrix will make it possible to recreate a microtissue in which inflammatory response and tissue remodeling phenomena can be studied in vitro,” explained Hélène Aerts, in charge of Biologie Servier’s in vitro platform. ...

ByPoietis


FDA Takes Action to Update Sunscreen Testing and Labeling and States Nanoscale Ingredients Are Not Absorbed

FDA Takes Action to Update Sunscreen Testing and Labeling and States Nanoscale Ingredients Are Not Absorbed

The groups submitted information purporting to show that nanomaterials had been found to penetrate cells and trigger inflammatory and immune responses. The Agency has yet formally to respond to the petition, despite addressing the issue obliquely in the myriad of materials released on sunscreen products. ...

ByBergeson & Campbell, P.C.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT